Investing
US FTC seeks additional info on Pfizer’s proposed takeover of Seagen
© Reuters. FILE PHOTO: The Pfizer logo is pictured on their headquarters building in the Manhattan borough of New York City, New York, U.S., November 9, 2020. REUTERS/Carlo Allegri/File Photo/File Photo
2/2
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related to Pfizer (NYSE:)’s proposed acquisition of Seagen Inc, Seagen said on Friday.
The antitrust agency sent the requests separately to both the companies, a regulatory filing said.
Pfizer struck a $43 billion deal in March to acquire Seagen and its targeted cancer therapies, to counter the fall in COVID-related sales and generic competition for some top-selling drugs.
The recent scrutiny by the antitrust agency to block Amgen (NASDAQ:)’s $27.8 billion deal to buy Horizon Therapeutics (NASDAQ:) has made investors jittery around the Pfizer-Seagen deal as well.
Seagan continues to expect its merger with Pfizer will be completed in late 2023 or early 2024, it said in the filing.
Read the full article here
-
Investing3 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Investing6 days ago
Are You Missing These Hidden Warning Signs When Hiring?
-
Passive Income3 days ago
How to Create a Routine That Balances Rest and Business Success
-
Make Money6 days ago
7 Common Things You Should Never Buy New
-
Side Hustles4 days ago
Apple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Side Hustles5 days ago
MIT Gives Free Tuition For Families Earning $200,000 or Less
-
Passive Income4 days ago
Customers Want More Than Just a Product — Here’s How to Keep Up
-
Investing6 days ago
Google faces call from DuckDuckGo for new EU probes into tech rule compliance By Reuters